Archives
|
Entry
|
Blogger
|
Date
▴
|
Location
|
|
Washington’s Life Sciences Ambassador, Jack Faris, Exits the Stage
|
Luke Timmerman |
12/29/08 |
Seattle
|
|
Where Tech Coast Angels Tread, And Why
|
Luke Timmerman |
12/24/08 |
San Diego
|
|
Lilly’s San Diego Biotechnology Center of Silence
|
Bruce V. Bigelow |
12/17/08 |
San Diego
|
|
Amgen’s Bid to Make Cancer Drug “Personalized” Lacks Data, FDA Panel Says
|
Luke Timmerman |
12/16/08 |
Seattle
|
|
Amgen Cancer Drug Getting Personal, Which May Be a Good Thing for Patients—and Sales
|
Luke Timmerman |
12/15/08 |
Seattle
|
|
Amylin Shares Soar as Diabetes Drug Catches a Break From FDA
|
Luke Timmerman |
12/11/08 |
San Diego
|
|
Ambrx Aims to Create New Breed of Custom-Built Biotech Drugs
|
Luke Timmerman |
12/08/08 |
San Diego
|
|
NitroMed and Archemix to Merge
|
Robert Buderi |
11/18/08 |
Boston
|
|
Ascent Therapeutics Climbs Out of Stealth Mode with “Pepducins”
|
Ryan McBride |
11/17/08 |
Boston
|
|
Amylin Cuts 340 Jobs, One Fourth of Staff, To Cope With Falling Diabetes Drug Demand
|
Luke Timmerman |
11/10/08 |
San Diego
|
|
Aileron Develops New Class of Drugs To Go Where None Could Before
|
Luke Timmerman |
11/07/08 |
Boston
|
|
Akamai Acquires Acerno, Archemix Adds Eli Lilly to Partner List, Sermo Signs Up Bloomberg Subscribers, & More Boston-Area Deals News
|
Rebecca Zacks |
10/27/08 |
Boston
|
|
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/22/08 |
Boston
|
|
Amylin Gets $125M from Eli Lilly To Make Once-Weekly Diabetes Drug
|
Luke Timmerman |
10/21/08 |
San Diego
|
|
Cypress Fibromyalgia Drug Stalled by FDA
|
Luke Timmerman |
10/20/08 |
San Diego
|
|
Archemix Looks to Hitch Eli Lilly to Aptamer Express in New Deal
|
Ryan McBride |
10/20/08 |
Boston
|
|
Allozyne Advances Toward Clinic, Sonosite Boots CFO, Leroy Hood’s Common Thread With Tupac, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/17/08 |
Seattle
|
|
CMC Icos Sees Expanding Markets for Biotech Drugs With New Factory
|
Luke Timmerman |
10/14/08 |
Seattle
|
|
Cypress Bioscience, Developer of Fibromyalgia Drug, Eagerly Awaits FDA Deadline
|
Luke Timmerman |
10/10/08 |
San Diego
|
|
Dendreon Stays in the Hunt, Lilly Makes Amends, Calistoga Hires First CEO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/09/08 |
Seattle
|
|
Lilly Patches Up Relationships in Seattle Biotech, Pushes TB Drug Discovery
|
Luke Timmerman |
10/07/08 |
Seattle
|
|
CMC/Icos Beefs Up Biotech Manufacturing in Bothell
|
Luke Timmerman |
09/29/08 |
Seattle
|
|
Governor’s Life Sciences Agency Makes Key Hire with MIT and Pharma Connections
|
Ryan McBride |
09/24/08 |
Boston
|
|
Targanta Aims to “Simplifi” Treatment of Deadly Bugs With Single-Shot Antibiotic
|
Luke Timmerman |
09/22/08 |
Boston
|
|
Cocrystal Discovery Raises $10 Million To Make Pills Against Viral Infections
|
Luke Timmerman |
09/19/08 |
Seattle
|
|
Discovery: The Soul of Biotech, the Place For True Believers, and a Retro Way to Bring it Back
|
Johnny Stine |
09/08/08 |
Seattle
|
|
After Cutting Deals With Most of the Big Drug Cos, Sermo CEO Offers Health 2.0 Survival Tip: You Will Not Pay Your Bills with “Ads by Google”
|
Ryan McBride |
08/28/08 |
Boston
|
|
MIT and Startup Sue Affymetrix, Enlight Garners Big Pharma Backers, Genocea Targets Cheaper Vaccines, & More Life Sciences News
|
Rebecca Zacks |
07/16/08 |
Boston
|
|
Big Drugmakers Pool Resources, Creating New Company Built to Improve R&D
|
Luke Timmerman |
07/10/08 |
Boston
|
|
Elixir Pulls IPO, Mascoma Runs With Marathon, InnoCentive Gets an Incentive, Novartis Ups Alnylam Stake, & More Deals News
|
Rebecca Zacks |
05/12/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
